Elsevier

Homeopathy

Volume 100, Issue 3, July 2011, Pages 122-130
Homeopathy

Original paper
The feasibility of a pragmatic randomised controlled trial to compare usual care with usual care plus individualised homeopathy, in children requiring secondary care for asthma

https://doi.org/10.1016/j.homp.2011.05.001Get rights and content

Objective

To test the feasibility of a pragmatic trial design with economic evaluation and nested qualitative study, comparing usual care (UC) with UC plus individualised homeopathy, in children requiring secondary care for asthma. This included recruitment and retention, acceptability of outcome measures patients’ and health professionals’ views and experiences and a power calculation for a definitive trial.

Methods

In a pragmatic parallel group randomised controlled trial (RCT) design, children on step 2 or above of the British Thoracic Society Asthma Guidelines (BTG) were randomly allocated to UC or UC plus a five visit package of homeopathic care (HC). Outcome measures included the Juniper Asthma Control Questionnaire, Quality of Life Questionnaire and a resource use questionnaire. Qualitative interviews were used to gain families’ and health professionals’ views and experiences.

Results

226 children were identified from hospital clinics and related patient databases. 67 showed an interest in participating, 39 children were randomised, 18 to HC and 21 to UC. Evidence in favour of adjunctive homeopathic treatment was lacking. Economic evaluation suggests that the cost of additional consultations was not offset by the reduced cost of homeopathic remedies and the lower use of primary care by children in the homeopathic group. Qualitative data gave insights into the differing perspectives of families and health care professionals within the research process.

Conclusions

A future study using this design is not feasible, further investigation of a potential role for homeopathy in asthma management might be better conducted in primary care with children with less severe asthma.

Introduction

The debate continues about provision of homeopathy in the National Health Service (NHS).1 The use of homeopathy and other complementary therapies is increasing, with a reported prevalence of 14.5% among asthma patients (adults and children) in a recent primary care survey.2 Data from the UK homeopathic hospitals indicate that childhood asthma is one of the ten most common reasons for referral.3, 4 The prevalence of asthma in children has increased over the past ten years and it constitutes a significant burden to children, their families and Health Services. Motivating factors for use of complementary and alternative medicine (CAM) vary but include parents’ wish to minimise use of steroids5 yet asthma remains a potentially life threatening condition where the use of regular conventional treatments is strongly recommended. Research into the role of homeopathy in this context is essential for patients to make informed and safe choices for their children’s health care.

Some in-vitro models of high homeopathic dilutions have yielded reproducible positive results.6 One study showed that low dose cytokines which have undergone ‘sequential kinetic activation’ were active in a mouse asthma model.7 A Cochrane review of homeopathy for asthma concluded available evidence was inconclusive and that, as well as randomised trials, there is a need for observational data to document the different methods of homeopathic prescribing.8 Observational data from clinical practice suggests that homeopathy can improve asthma for children.3, 9 Clinical trials in asthma have mainly centred around the use of isopathic homeopathic medicines, for example, an ultra molecular dilution of house dust mite to desensitise allergic triggers.10, 11

In routine clinical homeopathic practice individualised homeopathic prescriptions are considered more effective treatment because the body is viewed as a whole system to which the medicine is matched: symptoms of the mind and body are synthesised and a single remedy chosen. One trial of individualised homeopathy included a high proportion of children with very mild asthma and it was therefore difficult, due to floor and ceiling effects, to demonstrate a benefit of the intervention.12, 13 We therefore tested the feasibility of a possible future pragmatic randomised trial design in children with more severe asthma, who were at Step 2 or above on the British Thoracic Guidelines (BTG)14 and required secondary care input for their asthma management.

This study was designed to:

  • Establish whether we could successfully recruit and retain patients from this target population, whether randomisation was acceptable and other aspects of a larger trial.

  • Pilot the acceptability of outcome measures to study participants and explore between-group differences.

  • Explore patients’ and health professionals’ views and experiences of living with asthma, the research process and homeopathic treatment.

  • Pilot the feasibility of an economic evaluation using resource use questionnaires.

  • Enable a power calculation for a definitive trial.

Section snippets

Design

Following the Medical Research Council’s guidelines on the evaluation of complex interventions,15 this was a mixed methods study using both quantitative and qualitative research to investigate the research content and process. We used a pragmatic parallel randomised controlled trial design of ‘A versus [A + B]’, where A is usual care (UC) and B is homeopathic care (HC). The study was approved by the Oxfordshire Ethics Committee (05/Q1605/126 November 2005) and had approval from the Medicines and

Patient recruitment, retention and the acceptability of the research process

Figure 1 describes the participant flow through the study. The diagram includes information on the interventions received, outcome measures sent out and received and the number of patients actively followed up at different times during the trial. Recruitment was slow and a second recruitment site (SMH) was added following ethics approval. Despite aiming for a total sample size of 50–80, out of 226 potential families identified, 67 showed an interest in taking part and were sent the first pack

Discussion

This feasibility study was carried out to determine the best design for a future study to investigate whether a package of HC as delivered routinely in practice could safely and cost effectively improve asthma symptoms and quality of life in children with severe asthma. Findings suggested the complexity of the disease within the family context appeared to challenge the trial process and the homeopathic process. Qualitative and quantitative data highlighted poor asthma control in both groups and

Conclusion

From this pilot study of a pragmatic parallel group randomised controlled trial design to compare UC with UC plus individualised homeopathy, in children requiring secondary care for their asthma management, we conclude that a future trial of similar design is not feasible. Difficulties are predicted at various stages of the research process in this particular population of children. Quantitative data suggest that integrating homeopathy into existing conventional care would not confer additional

Acknowledgements

We thank all the children and adults who gave their time to this study and Dr Huw Thomas and the respiratory team of doctors and nurses at both recruiting sites and the Avon Primary Care Research Collaborative who funded the study. We thank Alan Montgomery for his help in the design and analysis of this study.

References (33)

  • M. Trichard et al.

    Pharmacoeconomic comparison between homeopathic and antibiotic treatment strategies in recurrent acute rhinopharyngitis in children

    Homeopathy

    (2005 Jan)
  • E. Ernst

    The truth about homeopathy

    Br J Clin Pharmacol

    (2008 Feb)
  • A. Shaw et al.

    Predictors of complementary therapy use among asthma patients: results of a primary care survey

    Health Soc Care Community

    (2008 Mar)
  • D.S. Spence et al.

    Homeopathic treatment for chronic disease: a 6-year, university-hospital outpatient observational study

    J Altern Complement Med

    (2005 Oct)
  • R.W. McCarney et al.

    Homeopathy for chronic asthma

    Cochrane Database Syst Rev

    (2004)
  • C.M. Witt et al.

    Homeopathic medical practice: long-term results of a cohort study with 3981 patients

    BMC Public Health

    (2005 Nov 3)
  • Cited by (15)

    • Efficacy of individualized homeopathy in bronchial asthma in adults: Double-blind, randomized, placebo-controlled, clinical trial in the context of usual care

      2019, Advances in Integrative Medicine
      Citation Excerpt :

      Our prescribing strategies were quite similar to that as perceived by Launsø et al. [41]. The study by Thompson et al. [25] reported poor asthma control without any additional medical or financial benefits from individualized homeopathy; however, the study solely depended on subjective assessment on quality of life outcomes. Prescribed remedies in our study, chronic or acute, were similar to those prescribed by Shafei et al. [42] and Ghosh et al. [43].

    • Depressed patients’ experiences with and perspectives on treatment provided by homeopaths. A qualitative interview study embedded in a trial

      2017, European Journal of Integrative Medicine
      Citation Excerpt :

      Optimism was also described by participants in some studies as an important characteristic emerging from consultations with homeopaths [25,26]. Others also found that patients could open up and unload [25,26,33], and explore their issues [25,27], which had similarities to our theme of reflection and realisation. Little can however be found in other studies suggesting that trust, safety and concerns were important issues and none mentioned the importance of the homeopath being an independent person, someone not otherwise involved in the patient’s life.

    • Health professionals' and families' understanding of the role of individualised homeopathy in asthma management for children requiring secondary care: Qualitative findings from a mixed methods feasibility study

      2013, European Journal of Integrative Medicine
      Citation Excerpt :

      Usual care varied depending on the needs of the individual. The results of the feasibility study using a mixed methods approach has been published [14], with the conclusion that ‘a future trial of similar design was not feasible’ for a population of children with such severe asthma. Quantitative data suggested that integrating homeopathy into existing medical care would not confer additional benefit either medically or financially.

    View all citing articles on Scopus
    View full text